|
⚲
|
| Keyboard |
| Morgan Stanley AIP GP LP
✚
|
|
|---|---|
| CRD # | 117050 |
| SEC # | 801-60699 |
| CIK # | 0001230207 |
| AUM | 40.85 B (2026-03-30) |
| Employees | 200 (84% Investors, 14% Brokers) |
| Fees | |
| Minimum | |
| Phone | 610-260-7600 |
| Address | 100 Front Street West Conshohocken, PA 19428 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($B) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/30/2026) [Brochure] |
|---|
Item 5 Fees and Compensation Hedge Funds and Opportunistic Investments For advisory services rendered to Clients pursuing a hedge fund or opportunistic investment strategy, AIP is generally entitled to a management fee in an amount (on an annualized basis) of up to (i) 1.50% of the net asset value of the applicable Fund or SMA, or (ii) 1.50% of the aggregate capital commitment to the applicable Fund or SMA. In the case of certain Funds, the fees charged by AIP may decrease over time upon the occurrence of certain events, as described in the governing materials of such Funds or SMAs. In some cases, AIP or one of its affiliates is also entitled to receive performance-based fees or allocations which may be up to 10% of the investor’s net profits and may be subject to a minimum hurdle rate and/or high-water mark. In addition, for certain Funds, an affiliate is generally entitled to carried interest with respect to each investor equal to 10% of such investor’s profits, subject to satisfaction of an 8% internal rate. Funds pursuing a hedge funds or opportunistic investment strategy generally book fees (and as applicable, incentive allocation estimates) on a monthly or quarterly basis. AIP also charges a fee to MSSB for providing services related to (i) conducting investment and operational due diligence on hedge funds; (ii) providing portfolio advisory services in connection with customized mandates; and (iii) managing a list of hedge funds into which qualified advisory Wealth Management clients may invest. Alternative Lending For advisory services rendered to the Alternative Lending Fund, AIP is entitled to a management fee in an amount of 0.75% on an annualized basis of the Alternative Lending Fund’s Managed Assets. “Managed Assets” means the total assets of the Alternative Lending Fund (including any assets attributable to borrowings for investment purposes) minus the sum of the Alternative Lending Fund’s accrued liabilities (other than liabilities representing borrowings for investment purposes). Omni Strategy For investment advisory services rendered to the Omni Fund, AIP is generally entitled to a management fee in an amount (on an annualized basis) ranging from 0.00% to 2.00% of the net asset value of each Omni Fund investor’s capital account. AIP or an affiliate of AIP is generally entitled to an incentive allocation with respect to each investor in the Omni Fund generally ranging from 0% to 20% of such investor’s profits, subject, with respect to certain series of interests, to satisfaction of a hurdle rate of 4%. The Omni Fund management fee is accrued monthly and payable quarterly in advance and is generally paid in arrears. While AIP does not intend to cause the Omni Fund to terminate its investment management relationship with AIP absent AIP’s reorganization, liquidation, or bankruptcy, the Omni Fund’s management fee will be prorated for partial periods. In addition to the management fee and incentive allocation payable by the Omni Fund to AIP and its affiliates, the Omni Fund will pay each Portfolio Manager an advisory fee and/or performance compensation based on the performance results achieved with respect to the Omni Fund’s investments managed by such Portfolio Manager. The Omni Fund may also pay a portion of a Portfolio Manager’s expenses (including expenses incurred in connection with its entering into an agreement with the Omni Fund) or pay certain advisory fees and performance compensation to the Portfolio Manager in advance. The Omni Fund may also pay one or more Portfolio Managers a guaranteed amount of advisory fees or expenses, which the Omni Fund would be required to pay even if AIP or the Omni Fund terminated the agreement with the applicable Portfolio Manager (“Portfolio Manager Agreement”) prior to a specified date. Any payments made or required to be made to, or in respect of, Portfolio Managers in connection with their management of the Omni Fund’s FORM ADV, PART 2A BROCHURE MORGAN STANLEY AIP GP LP 7 capital, including advisory fees, performance compensation and other payments, as well as payments made to AIP or its affiliates relating to Internal Portfolio Managers, are collectively referred to as “Trader Payouts.” Private Markets For investment advisory services rendered to the Funds pursuing a Private Markets investment strategy, AIP is occasionally entitled to a flat fee and more generally entitled to a management fee during the investment period in an amount (on an annualized basis) of up to 1.75% of either (i) the investor’s aggregate capital commitment to the Fund (ii) the investor’s attributable share of the aggregate capital commitments made by the Fund to its Underlying Investment Funds (based on the acquisition costs of such investments); (iii) the investor’s attributable share of the aggregate capital contributions made by the Fund to its Underlying Investment Funds (excluding amounts constituting a return of a capital contribution by such underlying investments); or (iv) the investor’s aggregate contributions with respect to Underlying Investment Funds plus the investor’s attributable share of the aggregate unfunded capital commitments made by the applicable Fund to its Underlying Investment Funds. In the case of certain Funds, the fees charged by AIP may decrease over time after the investment period ends, as described in the governing materials of such Funds. For funds that pursue a Private Markets strategy, the management fee will be charged in addition to an investor’s capital commitment. In most cases, AIP or one of its affiliates is also entitled to receive performance-based fees, which vary. AIP or an affiliate of AIP is generally entitled to carried interest with respect to each investor generally ranging from 5% - 15% of such investor’s profits, subject to satisfaction of an internal rate of return ranging from 6% - 15%, compounded annually. ... |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/30/2026) [Brochure] |
|---|
Item 7 Types of Clients AIP generally provides investment advice to registered and unregistered investment companies, pooled investment vehicles, separate accounts, funds of one, corporate/business entities, high net worth individuals, endowments, foundations, charitable institutions, sovereign wealth funds, foreign regulated funds such as UCITs, pension plans, insurance companies and domestic and foreign government agencies, and trusts. In addition, AIP, through its Hedge Fund Solutions business, provides investment research and operational due diligence services to MSSB, as previously discussed in Item 4. Investors who wish to participate in Funds are generally required to invest a certain minimum amount, which generally ranges (depending on the Fund) from $25,000 to $50 million. Certain Funds may have additional minimum investment requirements and may require that an investor is, among other things, an “accredited investor”, as defined under the Securities Act of 1933 (the “1933 Act”), as amended, and the applicable rules promulgated by the SEC thereunder, and/or a “qualified purchaser”, as defined under the Investment Company Act of 1940, as amended, and the applicable rules promulgated by the SEC thereunder (the “1940 Act”). The minimum account size for a separately managed account is negotiated on a case-by-case basis. Generally, a minimum amount of $25 million is required if a Wealth Management client wishes to engage AIP in connection with a customized portfolio account solution. FORM ADV, PART 2A BROCHURE MORGAN STANLEY AIP GP LP 13 |
| Sector | Form 13F Holdings | Value ($T) | |
|---|---|---|---|
| Apple Inc | 0.1 | ||
| Nvidia Corp | 0.1 | ||
| Microsoft Corp | 0.0 | ||
| Amazon Com Inc | 0.0 | ||
| Alphabet Inc | 0.0 | ||
| Broadcom Inc | 0.0 | ||
| Facebook Inc | 0.0 | ||
| Alphabet Inc | 0.0 | ||
| J P Morgan Chase & Co | 0.0 | ||
| Tesla Motors Inc | 0.0 | ||
| View All | |||
| Holdings by Sector ($T) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| Other | Hedge Fund Core Primaries Series 1 A Series of Riverview Multi-Client Solutions Fund LP | [2026-03-30] | 89.5 M | 96.1 M |
| Filed 2026-01-16 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| Other | Montserrat Fund Cayman LP | 2026-03-30 | 53.5 M | |
| Other | Orion Private Equity Partners Fund LP | [2026-03-30] | 11.0 M | |
| Filed 2025-04-14 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $250,000 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| Other | Riverview Alpha Strategies Q AIV LP | 2026-03-30 | 204.7 M | |
| Other | Riverview Alpha Strategies Q LP | 2026-03-30 | 374.0 M | |
| Other | Tandem SPV LP | 2026-03-30 | 127.8 M | |
| PE | 1GT Fund LP | [2025-03-28] | 25.7 M | |
| Filed 2023-12-15 (D) · Exemption 506(c), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $750,000 · Net Assets Decline to Disclose | ||||
| Other | North Haven Ashbridge Co-Investment Opportunity B LP | [2025-03-28] | 64.1 M | |
| Filed 2024-10-04 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose | ||||
| Other | North Haven Private Equity Co-Investment Opportunities Fund III Splitter Lux SCSP | [2025-03-28] | 87.6 M | |
| Filed 2024-05-15 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $225,000 · Net Assets Decline to Disclose | ||||
| Other | PSG Private Credit LP | [2025-03-28] | 300.6 M | 71.7 M |
| Filed 2024-07-18 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 16 | 0.5 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 4 | 2.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 124 | 32.4 |
| (g) Pension and profit sharing plans | 4 | 0.8 |
| (h) Charitable organizations | 8 | 0.2 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 2 | 0.0 |
| (k) Insurance companies | 1 | 0.7 |
| (l) Sovereign wealth funds and foreign official institutions | 3 | 0.3 |
| (m) Corporations or other businesses not listed above | 36 | 4.0 |
| (n) Other | 1 | 0.0 |
| Total | 199 | 40.9 |
| By Discretionary | ||
| Discretionary | 184 | 40.1 |
| Non-Discretionary | 15 | 0.8 |
| Total | 199 | 40.9 |
| By Non-United States Persons | ||
| Non-United States Persons | 14.9 | |
| United States Persons | 25.9 | |
| Total | 199 | 40.9 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Charles Thomas | Director | 160 | 30 | |
| Campbell Congdon | Director | 179 | 28 | |
| Jason Sneah | Director, Executive Officer | 189 | 25 | |
| Tim Woolaver | Director | 90 | 25 | |
| Khalid Iton | Director, Executive Officer | 109 | 22 | |
| Peter Huber | Director | 88 | 22 | |
| Sam Ellis | Director | 106 | 18 | |
| Wendy Zhang | Director | 46 | 15 | |
| David Miller | Director | 298 | 14 | |
| Stephane Lachance | Director | 143 | 14 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001230207] | |
| 3 | [0001230207] | |
| 4 | [0001230207] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $4.9B |
| Serves | Institutional, Retail |
| Fund Types | Hedge Fund, Private Equity, Real Estate |
| LEI | 549300KSRL5W75JNE398 |
| Related People Network |
|---|
| 206 people file Form D offerings alongside this firm's people, tied to 24 other firms through shared filers. |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Morgan Stanley AIP GP LP | |
| North Haven Private Assets Fund | |
| Morgan Stanley Investment Management Inc | |
| Sagent Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2015-01-27 | Sell | 50,000 | $26.19 | 1,309,500 |
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2015-01-26 | Sell | 28,041 | $26.12 | 732,431 |
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2015-01-23 | Sell | 61,883 | $25.90 | 1,602,770 |
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2015-01-22 | Sell | 150,000 | $25.49 | 3,823,500 |
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2015-01-21 | Sell | 44,316 | $25.22 | 1,117,650 |
|
Sagent Pharmaceuticals Inc SGNT
common stock
|
2015-01-20 | Sell | 25,000 | $25.24 | 631,000 |
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2015-01-16 | Sell | 50,000 | $25.26 | 1,263,000 |
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2015-01-15 | Sell | 75,000 | $25.10 | 1,882,500 |
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2015-01-14 | Sell | 50,000 | $25.53 | 1,276,500 |
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2015-01-13 | Sell | 50,000 | $25.49 | 1,274,500 |
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2013-10-03 | Sell | 47,826 | $20.27 | 969,433 |
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2013-10-02 | Sell | 40,020 | $20.32 | 813,206 |
|
Sagent Pharmaceuticals Inc SGNT
Common Stock
|
2013-10-01 | Sell | 50,000 | $20.70 | 1,035,000 |
|
Sagent Pharmaceuticals Inc SGNT
common stock
|
2013-09-30 | Sell | 28,872 | $20.46 | 590,721 |
|
Sagent Pharmaceuticals Inc SGNT
common stock
|
2013-09-30 | Sell | 25,000 | $20.38 | 509,500 |
|
Sagent Pharmaceuticals Inc SGNT
common stock
|
2013-09-27 | Sell | 10,000 | $20.60 | 206,000 |
|
Sagent Pharmaceuticals Inc SGNT
common stock
|
2013-09-27 | Sell | 31,300 | $20.52 | 642,276 |
|
Sagent Pharmaceuticals Inc SGNT
common stock
|
2013-09-26 | Sell | 67,965 | $20.37 | 1,384,447 |
|
Sagent Pharmaceuticals Inc SGNT
common stock
|
2013-09-25 | Sell | 33,431 | $21.22 | 709,406 |
|
Sagent Pharmaceuticals Inc SGNT
common stock
|
2013-09-24 | Sell | 14,693 | $21.50 | 315,900 |
| showing 20 of 24 most recent transactions | |||||
| Related Firms | State | AUM |
|---|---|---|
|
Morgan Stanley Smith Barney LLC
✚
|
NY | 1,961.89 B |
|
Morgan Stanley Investment Management Inc
✚
|
NY | 702.25 B |
|
Morgan Stanley Investment Management Limited
✚
|
174.54 B | |
|
Morgan Stanley AIP GP LP
✚
|
PA | 40.85 B |
|
MS Capital Partners Adviser Inc
✚
|
NY | 38.76 B |
|
Morgan Stanley Infrastructure Inc
✚
|
NY | 15.97 B |
|
MSREF Real Estate Advisor Inc
✚
|
NY | 15.77 B |
|
Morgan Stanley Investment Management Company
✚
|
10.94 B | |
|
Morgan Stanley Private Equity Asia Inc
✚
|
NY | 1,864.3 M |
|
MSRESS III Manager LLC
✚
|
NY | 39.6 M |
|
Morgan Stanley Smith Barney Venture Services LLC
✚
|
NY | |
|
MSREF V LLC
✚
|
NY | |
|
Morgan Stanley Real Estate Advisor Inc
✚
|
NY |
| Comparable Firms | State | AUM |
|---|---|---|
|
Mai Capital Management LLC
✚
|
OH | 52.10 B |
|
SCS Capital Management LLC
✚
|
MA | 48.65 B |
|
Abrdn Inc
✚
|
PA | 41.48 B |
|
Strategic Investment Management LLC
✚
|
VA | 35.51 B |
|
Luther King Capital Management Corporation
✚
|
TX | 31.50 B |
|
Tiedemann Advisors LLC
✚
|
NY | 31.01 B |
|
Waverly Advisors LLC
✚
|
AL | 29.78 B |
|
Oxford Financial Group Ltd LLC
✚
|
IN | 23.33 B |
|
Jordan Park Group LLC
✚
|
CA | 23.26 B |
|
Ehrenkranz Partners LP
✚
|
NY | 21.54 B |